Fevisafe 400 Tablet
Marketer
Safecon Lifesciences
Salt Composition
Favipiravir (400mg)
Overview Fevisafe 400 Tablet
Viracept 400mg tablets offer antiviral therapy for managing mild to moderate COVID-19 in adults. This medication inhibits viral replication, thus reducing the body's viral burden. Always adhere to your physician's prescribed dosage and regimen; avoid self-prescribing. Commonly reported adverse reactions include elevated blood uric acid, diarrhea, neutropenia, and increased hepatic enzymes. Report any concerning side effects to your doctor immediately. Prior to commencing treatment, disclose any history of severe hepatic or renal impairment to ensure suitability. Viracept 400mg is contraindicated in pregnant or breastfeeding women, and those who suspect pregnancy, due to potential harm to the fetus. Patients with a history of hypersensitivity to this medication, uric acid metabolic disorders, or gout should inform their doctor before use.
Primary Ingredients of Fevisafe 400 Tablet
No information provided. Unable to rewrite.
Uses of Fevisafe 400 Tablet
Managing the infection caused by the SARS-CoV-2 virus
Major Benefits of Fevisafe 400 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Fevisafe 400 Tablets can be consumed with or without food, however, consistency in timing is recommended.
Common Side effects of Fevisafe 400 Tablet:
- Increased uric acid level in blood
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Increased liver enzymes
- Increased triglyceride level in blood
How to use Fevisafe 400 Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Fevisafe 400 Tablets can be consumed with or without food, though consistent timing is recommended.
How Fevisafe 400 Tablet works:
Favipiravir 400mg tablets possess antiviral properties, inhibiting SARS-CoV-2 replication. This action reduces the viral burden, limiting infection transmission and accelerating recovery.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Fevisafe 400 Tablet may pose unknown risks; physician consultation is advised.
PregnancyUNSAFE
Taking Fevisafe 400 tablets while pregnant poses a serious risk. Pregnant women should consult their physician, as research in both animals and pregnant humans indicates substantial harm to the fetus.
Breast feedingUNSAFE
Lactation and the use of Fevisafe 400 tablets are incompatible. Evidence indicates a potential for infant harm from this medication.
DrivingCONSULT YOUR DOCTOR
The effect of Fevisafe 400 Tablet on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with significant kidney impairment should exercise caution when using Fevisafe 400 Tablets. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with advanced liver impairment should use Fevisafe 400mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Fevisafe 400 Tablet :
Should you forget a Fevisafe 400 Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Fevisafe 400 Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrazinecarboxamide analog |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |

